Next-generation, inhaled COVID-19 vaccine enters phase-2 clinical trial

Post author:admin
Post published:March 10, 2025
Post category:uncategorized

Researchers at McMaster University have started a phase-2 clinical trial on a next-generation, inhaled COVID-19 vaccine.

Empowering individuals with knowledge, fostering healthier lifestyles, and fostering a community dedicated to diabetes awareness and prevention. Together, we’re shaping a healthier future.

Helpful Links

Subscribe To Us

By submitting via this part of the website you are granting us permission to store and process your data according to our Standard privacy policy

UPCOMING EVENTS

You Might Also Like

Evaluating systemic thrombolysis for acute portal vein thrombosis in cirrhotic patients

Urinary pentosidine reveals muscle and performance health in young men

Are big retail chains driving global obesity? Study confirms alarming link

Helpful Links

Subscribe To Us